Suite 420A
Philadelphia, PA 19107
(215) 955-8874
Most Recent Peer-reviewed Publications
- Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: Implications for PET imaging of human tumors
- Understanding the metabolic basis of drug resistance: Therapeutic induction of the Warburg effect kills cancer cells
- Cytokine production and inflammation drive autophagy in the tumor microenvironment: Role of stromal caveolin-1 as a key regulator
- Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts
- HLA-C Antigen Mismatch Is Associated with Worse Outcome in Unrelated Donor Peripheral Blood Stem Cell Transplantation
Medical School
Jefferson Medical College - 1976
Residency
Albert Einstein College of Medicine, NY
Fellowship
Memorial Sloan-Kettering Cancer Center, NY
Board Certification
Medical Oncology
Hematology
Internal Medicine
Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital
University Appointment
Chairman, Medical Oncology
Professor
Research & Clinical Interests
Medical Oncology, Hematology-Oncology, Bone Marrow Transplant, Hematologic Malignancies, Leukemia, Lymphoma
Dr. Flomenberg is the Chairman of Medical Oncology and also heads the Hematologic Malignancies, Blood and Marrow Transplantation (BMT) Program. He has had a longstanding interest in the immunogenetics and immunology of stem cell transplantation, with the goal of making transplantation safer and more widely available.